問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
葉宗讓
下載
2024-01-01 - 2027-07-31
Condition/Disease
test
Test Drug
Participate Sites6Sites
Recruiting6Sites
2023-04-01 - 2026-08-30
Malignant Solid Tumors
liquid
Participate Sites7Sites
Recruiting7Sites
2023-11-01 - 2028-12-31
2022-08-22 - 2026-07-31
Participate Sites1Sites
Recruiting1Sites
2022-02-01 - 2026-12-31
Participate Sites5Sites
Recruiting5Sites
2021-10-13 - 2024-08-31
Recruiting4Sites
Terminated1Sites
2025-07-31 - 2028-09-01
2024-12-01 - 2032-12-31
2023-06-01 - 2030-03-28
Not yet recruiting3Sites
Recruiting3Sites
2023-07-01 - 2029-02-28
Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)
injection
Participate Sites12Sites
Recruiting12Sites
全部
